About Me
Douglas Tremblay, MD is an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Tremblay completed fellowship and residency training at Mount Sinai where he served as both Chief Fellow and Chief Resident. His clinical and translational research focus is on hematologic malignancies, particularly acute myeloid leukemia (AML), myeloproliferative neoplasms (MPNs), and myelodysplastic/myeloproliferative overlap syndromes. Dr. Tremblay has led multi-institutional research efforts in MPNs and is actively involved in both investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms.
Language
Position
ASSISTANT PROFESSOR | Medicine, Hematology and Medical OncologyHospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Morningside and Mount Sinai West
About Me
Douglas Tremblay, MD is an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Tremblay completed fellowship and residency training at Mount Sinai where he served as both Chief Fellow and Chief Resident. His clinical and translational research focus is on hematologic malignancies, particularly acute myeloid leukemia (AML), myeloproliferative neoplasms (MPNs), and myelodysplastic/myeloproliferative overlap syndromes. Dr. Tremblay has led multi-institutional research efforts in MPNs and is actively involved in both investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms.
Language
Position
ASSISTANT PROFESSOR | Medicine, Hematology and Medical OncologyHospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Morningside and Mount Sinai West
About Me
Douglas Tremblay, MD is an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Tremblay completed fellowship and residency training at Mount Sinai where he served as both Chief Fellow and Chief Resident. His clinical and translational research focus is on hematologic malignancies, particularly acute myeloid leukemia (AML), myeloproliferative neoplasms (MPNs), and myelodysplastic/myeloproliferative overlap syndromes. Dr. Tremblay has led multi-institutional research efforts in MPNs and is actively involved in both investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms.
Language
Position
ASSISTANT PROFESSOR | Medicine, Hematology and Medical OncologyHospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Morningside and Mount Sinai West
Clinical Focus
- Acute Myeloid Leukemia
- Anemia
- Chronic Myelocytic Leukemia
- Eosinophilia
- Essential Thrombocythemia
- Leukemia
- Myelodysplastic Syndromes
- Myelofibrosis
- Myeloproliferative Neoplasms (MPN)
Show More
- Acute Myeloid Leukemia
- Anemia
- Chronic Myelocytic Leukemia
- Eosinophilia
- Essential Thrombocythemia
- Leukemia
- Myelodysplastic Syndromes
- Myelofibrosis
- Myeloproliferative Neoplasms (MPN)
- Polycythemia Vera
- Primary Polycythemia
Education
MD, Albert Einstein College of Medicine
Residency , Internal Medicine
The Mount Sinai Hospital
Fellowship, Hematology-Oncology
Mount Sinai Hospital
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Tremblay during 2021 and/or 2022. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- MPN Research Foundation
- AbbVie Inc.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- Real CME
- Primum
- DAVA Oncology, LP
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Doctors
Accepting New Patients
